Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis

Alcohol and Alcoholism

Volumn 49, Issue 4, 2014, Pages 453-456

  Yamini, David ^a   Lee, Scott Hyunsoo ^a   Avanesyan, Armine ^a   Walter, Michael ^a   Runyon, Bruce ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BACLOFEN; BILIRUBIN; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALBUMINOID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; MELD SCORE; OPEN STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; COMPLICATION; HEPATITIS, ALCOHOLIC; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALBUMINS; ALCOHOL ABSTINENCE; ALCOHOLISM; ASPARTATE AMINOTRANSFERASES; BACLOFEN; BILIRUBIN; FEMALE; GABA-B RECEPTOR AGONISTS; HEPATITIS, ALCOHOLIC; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84902474340     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu028     Document Type: Article

References (27)

1. Addolorato G, Caputo F, Capristo E et al. (2000) Ability of baclofen in reducing alcohol craving and intake: II-preliminary clinical evidence. Alcohol Clin Exp Res 24:67-71.
2. Addolorato G, Caputo F, Capristo E et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37:504-8.
3. Addolorato G, Leggio L, Ferrulli A et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-22.
4. Addolorato G, Leggio L, Ferrulli A et al. (2011) Dose-response effect of baclofen in reducing daily alcohol intake in alcoholdependent subjects: secondary analysis of a randomized doubleblind placebo controlled trial. Alcohol Alcohol 46:312-7.
5. Ameisen O. (2005) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 40:147-50.
6. Bucknam W. (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol 42:158-60.
7. Choi G, Runyon B. (2012) Alcoholic hepatitis: a clinician's guide. Clin Liver Dis 16:371-85.
8. Colombo G, Serra S, Brunetti G et al. (2002) The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behavior in alcohol-preferring rats. Alcohol Alcohol 37:499-503.
9. Daoust M, Saligaut C, Lhuintre JP et al. (1987) GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 4:469-72.
10. DavidoffRA. (1985) Antispasticity drugs: mechanisms of action. Ann Neurol 17:107-16.
11. Dore GM, Lo K, Juckes L et al. (2011) Clinical experience with baclofen in the management of alcohol-dependent patients with psychiatric comorbidity: a selected case series. Alcohol Alcohol 46:714-72.
12. Evans SM, Bisaga A. (2009) Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res 33:19-30.
13. Flannery BA, Garbutt JC, Cody MW et al. (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 28:1517-23.
14. Garbutt J, Kampov-Polevoy A, Gallop R et al. (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-57.
15. Heydtmann M, Macdonald B, Lewsey J et al. (2012) The GABA-B agonist baclofen improves alcohol consumption, psychometrics and may have an effect on the hospital admission rates of patients with alcoholic liver disease. Hepatology 56:1091A.
16. Leggio L, Ferrulli A, Cardone S et al. (2008a) Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol 42:375-81.
17. Leggio L, Ferrulli A, Malandrino N et al. (2008b) Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients. Alcohol Clin Exp Res 32:450-8.
18. Leggio L, Garbutt JC, Addolorato G. (2010) Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Neurol Disord Drug Targets 9:33-44.
19. Leggio L, Ferrulli A, Zambon A. (2012) Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav 37:561-4.
20. Leggio L, Zywiak WH, McGeary JE et al. (2013) A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav 103:784-91.
21. Luca A, Garcia-Pagan JC, Bosch J et al. (1997) Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 112:1284-9.
22. Maccioni P, Colombo G. (2009) Role of the GABA(B) receptor in alcohol-seeking and drinking behavior. Alcohol 43:555-8.
23. Müting D, Kalk JF, Fischer R et al. (1990) Spontaneous regression of esophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver cirrhosis, posthepatitic cirrhosis and haemochromatosis with cirrhosis. J Hepatol 10:158-62.
24. Rigal L, Alexandre-Dubroeucq C, Paire R et al. (2012) Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers. Alcohol Alcohol 47:439-42.
25. Walker BM, Koob GF. (2007) The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31:11-8.
26. http://pubs.niaaa.nih.gov/publications/economic-2000/#table3.
27. http://www2.costco.com/Pharmacy/DrugInfo.aspx?p=1&SearchTerm=baclofen&Drug=BACLOFEN.